-transparent.png){kind=logo}
A case of serum sickness was observed 7 days after administration of intravenous streptokinase in the acute phase of myocardial infarction. The clinical presentation was the sudden development of fever, a papuloerythematous skin rash, myalgia and polyarthritis accompanied by a severe biological inflammatory syndrome without any signs of bacterial or viral infection. Spontaneous regression was observed within 72 hours. Although this complication of streptokinase fibrinolysis seems to be rare, clinicians should be aware of it and not confuse the allergic reaction with that of another drug, the withdrawal of which could be prejudicial for the patient.
Related Publications
F Albert, and
O Dubourg, and
G Steg, and
G Delorme, and
J P Bourdarias
December 1984,
European heart journal,
F Albert, and
O Dubourg, and
G Steg, and
G Delorme, and
J P Bourdarias
April 1990,
Clinical and experimental immunology,
F Albert, and
O Dubourg, and
G Steg, and
G Delorme, and
J P Bourdarias
February 1983,
The New England journal of medicine,
F Albert, and
O Dubourg, and
G Steg, and
G Delorme, and
J P Bourdarias
October 1983,
The Western journal of medicine,
F Albert, and
O Dubourg, and
G Steg, and
G Delorme, and
J P Bourdarias
January 1991,
Cardiology,
F Albert, and
O Dubourg, and
G Steg, and
G Delorme, and
J P Bourdarias
April 1991,
Journal of the American Academy of Dermatology,
F Albert, and
O Dubourg, and
G Steg, and
G Delorme, and
J P Bourdarias
May 1985,
Annals of emergency medicine,
F Albert, and
O Dubourg, and
G Steg, and
G Delorme, and
J P Bourdarias
May 1983,
Drug intelligence & clinical pharmacy,
F Albert, and
O Dubourg, and
G Steg, and
G Delorme, and
J P Bourdarias
June 1985,
Harefuah,
F Albert, and
O Dubourg, and
G Steg, and
G Delorme, and
J P Bourdarias
February 1988,
Arquivos brasileiros de cardiologia,
